Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 5,000 shares at $70.55 ($353K) on 2023-11-30, disclosed to the SEC on 2023-12-04.
Open-market sale of $353k BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |